3.2 GLIM Criteria for Malnutrition Diagnosis in Oncology

GLIM Criteria for Malnutrition Diagnosis in Oncology

The Global Leadership Initiative on Malnutrition (GLIM) framework represents a major milestone in clinical nutrition. Formed by the leading global clinical nutrition societies—including the American Society for Parenteral and Enteral Nutrition (ASPEN), European Society for Clinical Nutrition and Metabolism (ESPEN), Latin American Federation of Nutritional Therapy, Clinical Nutrition and Metabolism (FELANPE), and Parenteral and Enteral Nutrition Society of Asia (PENSA)—GLIM provides a unified, standardized diagnostic construct for adult malnutrition across healthcare settings worldwide.

In oncology care, GLIM fills a critical gap by cleanly separating phenotypic expressions of malnutrition (what tissue deficits are physically present) from etiologic drivers (why the deficits have occurred). This separation is crucial in cancer, where systemic inflammation driven by tumor-host interactions acts as a chronic metabolic driver of catabolism.

---

The Two-Step Diagnostic Model

GLIM mandates a structured two-step operational process for clinical diagnosis:

1. Step 1: First-Line Screening — Administer a validated nutritional screening tool (e.g., PG-SGA, MUST, NRS-2002, MST) to identify patients 'at risk' of malnutrition.
2. Step 2: Diagnostic Assessment — Evaluate patients identified as 'at risk' against the GLIM phenotypic and etiologic criteria to confirm malnutrition diagnosis and establish severity.

+-----------------------------------------------------------------------+
|                   GLIM TWO-STEP DIAGNOSTIC MODEL                     |
+-----------------------------------------------------------------------+
| STEP 1: SCREENING                                                     |
|  - Conduct validated screen (PG-SGA, MUST, NRS-2002, MST)             |
|  - If Result = 'At Risk', proceed directly to Step 2                  |
+-----------------------------------------------------------------------+
| STEP 2: DIAGNOSTIC ASSESSMENT                                         |
|  - Must fulfill AT LEAST 1 Phenotypic Criterion AND 1 Etiologic       |
|  - Phenotypic: Weight Loss, Low BMI, Reduced Muscle Mass              |
|  - Etiologic: Reduced Intake/Assimilation, Disease Burden/Inflammation|
+-----------------------------------------------------------------------+
| STEP 3: SEVERITY GRADING                                              |
|  - Grade based on most severe Phenotypic criterion present            |
|  - Stage 1: Moderate Malnutrition  | Stage 2: Severe Malnutrition    |
+-----------------------------------------------------------------------+

---

Core Diagnostic Criteria

To establish a formal diagnosis of malnutrition under GLIM, a patient must meet at least ONE Phenotypic Criterion AND at least ONE Etiologic Criterion.

1. Phenotypic Criteria (Physical & Morphological Expression)

Phenotypic criteria reflect measurable alterations in body weight, body mass index, and body composition:

• Unintended Weight Loss:
  • $>5%$ within the past 6 months, OR
  • $>10%$ beyond 6 months.
• Low Body Mass Index (BMI):
  • $<20\text{ kg/m}^2$ if age $<70$ years.
  • $<22\text{ kg/m}^2$ if age $\ge 70$ years.
  • Asian Population Cutoffs: $<18.5\text{ kg/m}^2$ if age $<70$ years; $<20\text{ kg/m}^2$ if age $\ge 70$ years.
• Reduced Muscle Mass:
  • Deficits confirmed via validated objective modalities: Dual-Energy X-ray Absorptiometry (DEXA), Bioelectrical Impedance Analysis (BIA), Computed Tomography (CT at L3 vertebra), or Nutrition-Focused Physical Exam (NFPE) demonstrating muscle wasting.

2. Etiologic Criteria (Metabolic & Ingestion Drivers)

Etiologic criteria capture the underlying mechanisms causing phenotypic deficits:

• Reduced Food Intake or Assimilation:
  • $\le 50%$ of energy requirements for $>1$ week, OR any reduction in intake for $>2$ weeks, OR
  • Chronic gastrointestinal (GI) conditions that impair nutrient absorption or assimilation (e.g., short bowel syndrome, severe radiation enteritis, pancreatic exocrine insufficiency, malignant bowel obstruction, post-gastrectomy malabsorption).
• Disease Burden / Systemic Inflammation:
  • Acute disease/injury OR chronic disease-related inflammation. In oncology, active solid tumors, hematologic malignancies, surgical trauma, or treatment-induced systemic inflammation meet this criterion, supported by elevated serum C-Reactive Protein (CRP $>10\text{ mg/L}$).

---

Severity Grading Framework

Once a malnutrition diagnosis is confirmed (meeting $\ge 1$ Phenotypic + $\ge 1$ Etiologic criterion), the severity is graded based on the most severe phenotypic criterion present:

---

Practical Clinical Application & Pitfalls in Oncology

1. The Inflammatory Baseline

In oncology, active malignant disease almost universally satisfies the disease burden / inflammation etiologic criterion. As a result, the diagnostic challenge shifts primarily to accurately identifying phenotypic criteria. Clinicians must actively screen for weight loss and muscle mass depletion even when patients present with normal or elevated BMI.

2. Sarcopenic Obesity & Masked Malnutrition

A critical pitfall in oncology is missing malnutrition in overweight or obese patients (BMI $\ge 25 - 30\text{ kg/m}^2$). Obese patients with aggressive muscle wasting (sarcopenic obesity) meet GLIM criteria if they exhibit $>5%$ weight loss or reduced muscle mass on CT/BIA/NFPE, despite having a high BMI. In these cases, low BMI threshold criteria are not met, but weight loss or muscle mass loss criteria confirm the diagnosis.

3. Adjusting for Fluid Retention

Malignant ascites, pleural effusions, and chemotherapy-induced edema inflate body weight, concealing true tissue loss. Clinicians must use estimated dry body weight (deducting $5 - 15\text{ kg}$ depending on ascites severity) when calculating weight loss percentages and BMI for GLIM assessment.

---

Detailed Worked Clinical Case Study

Patient Presentation

A 71-year-old female with stage IV pancreatic adenocarcinoma receiving palliative chemotherapy presents for outpatient evaluation. She reports progressive fatigue and early satiety.

• Height: $162\text{ cm}$
• Scale Weight: $54\text{ kg}$ (Usual Weight 6 months ago = $62\text{ kg}$). Scale weight reflects mild pedal edema ($1+$ pitting).
• Calculated Dry Weight: $52.5\text{ kg}$ (deducting $1.5\text{ kg}$ fluid).
• Dietary History: Consuming approximately $40%$ of estimated energy requirements for the past 12 days.
• Laboratory Findings: Serum CRP = $24\text{ mg/L}$ (elevated).

Diagnostic Step-by-Step Evaluation

1. Step 1 (Screening): PG-SGA score = $10$ (Identified as 'At Risk' $\rightarrow$ proceed to GLIM).
2. Step 2 (GLIM Diagnostic Combination):
   • Etiologic Criteria: Fulfills BOTH criteria:
     • Reduced intake: $<50%$ of needs for $>1$ week ($40%$ for 12 days).
     • Inflammation/Disease Burden: Stage IV pancreatic cancer with elevated CRP ($24\text{ mg/L}$). * Phenotypic Criteria: Fulfills BOTH weight loss and low BMI criteria:
     • Unintended Weight Loss: $[(62 - 52.5) / 62] \times 100 = 15.3%$ over 6 months.
     • Low BMI: Dry BMI = $52.5 / (1.62)^2 = 20.0\text{ kg/m}^2$ (Threshold for age $\ge 70$ is $<22.0\text{ kg/m}^2$).
   • Diagnostic Conclusion: Malnutrition Confirmed ($\ge 1$ Phenotypic + $\ge 1$ Etiologic).
3. Step 3 (Severity Grading):
   • Weight loss is $15.3%$ over 6 months ($>10%$ threshold for Stage 2).
   • Dry BMI is $20.0\text{ kg/m}^2$ (falls into Stage 2 severe range for age $\ge 70$, which is $<20.0\text{ kg/m}^2$).
   • Final Diagnosis: Stage 2 (Severe) Malnutrition.